| Followers | 131 |
| Posts | 15004 |
| Boards Moderated | 0 |
| Alias Born | 06/04/2018 |
Thursday, October 15, 2020 6:00:35 PM
NEWS: $ARWR Why Arrowhead Pharmaceuticals Stock Jumped Today
Shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR) rose sharply on Thursday and closed today's trading session up 9.9% after climbing by as much as 14.4%. The drugmaker did not report any news, but biotech giant Vertex Pharmaceuticals (NASDAQ:VRTX) released an update regardin...
In case you are interested ARWR - Why Arrowhead Pharmaceuticals Stock Jumped Today
Shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR) rose sharply on Thursday and closed today's trading session up 9.9% after climbing by as much as 14.4%. The drugmaker did not report any news, but biotech giant Vertex Pharmaceuticals (NASDAQ:VRTX) released an update regardin...
In case you are interested ARWR - Why Arrowhead Pharmaceuticals Stock Jumped Today
Recent ARWR News
- Form 144/A - Report of proposed sale of securities: [Amend] • Edgar (US Regulatory) • 05/19/2026 08:46:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 11:05:44 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/12/2026 08:35:16 PM
- Wall Street's Cardiac Bet: Where Diagnostics Meet the Money • PR Newswire (US) • 05/12/2026 12:30:00 PM
- Wall Street's Cardiac Bet: Where Diagnostics Meet the Money • PR Newswire (Canada) • 05/12/2026 12:30:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/07/2026 09:27:41 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 08:05:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 08:02:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/24/2026 10:44:42 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/23/2026 08:44:48 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/22/2026 09:16:20 PM
- Anti-Aging Protein Research Takes a Step Forward with Cell Cloning • PR Newswire (Canada) • 03/24/2026 03:05:00 PM
- Anti-Aging Protein Research Takes a Step Forward with Cell Cloning • PR Newswire (US) • 03/24/2026 03:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/20/2026 08:05:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 11:00:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2026 09:49:43 PM
- Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A • InvestorsHub NewsWire • 02/17/2026 02:00:00 PM
- Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A • GlobeNewswire Inc. • 02/17/2026 01:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/05/2026 09:06:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2026 09:05:15 PM
- Ciena Set to Join S&P 500; Arrowhead Pharmaceuticals to Join S&P MidCap 400; ADT and OneSpaWorld Holdings to Join S&P SmallCap 600 • PR Newswire (US) • 02/04/2026 11:15:00 PM
